A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein

Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are two leading causes of severe respiratory infections in children, the elderly, and immunocompromised patients. The fusion (F) protein is the major target of neutralizing antibodies. Recent developments in stabilizing the pre-fusio...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Jiachen Huang, Rose J. Miller, Jarrod J. Mousa
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2022-08-01
Cyfres:	Frontiers in Immunology
Pynciau:	RSV (respiratory syncytial virus) human metapneumovirus (hMPV) vaccine structure-based vaccine design neutralizing antibodies fusion protein
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.941865/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!